KEYMED BIOSCIENCES -0001 Working Capital to Net Assets Ratio
KEYMED BIOSCIENCES -0001 working capital to net assets ratio. KEYMED BIOSCIENCES -0001 (64Z) has a Working Capital to Net Assets ratio of 57.2% as of December 2025. Working capital of €1.59 Billion (current assets of €2.42 Billion minus current liabilities of €836.29 Million) is measured against net assets of €2.77 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check 64Z goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of KEYMED BIOSCIENCES -0001 (2021–2025)
Working capital to net assets ratio of KEYMED BIOSCIENCES -0001 from 2021 to 2025. This chart shows how KEYMED BIOSCIENCES -0001's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 57.2%, reflecting working capital of €1.59 Billion against net assets of €2.77 Billion EUR. See 64Z days of operational coverage to measure how many days the company can operate on defensive assets alone.
KEYMED BIOSCIENCES -0001 Working Capital to Net Assets Ratio by Year (2021–2025)
KEYMED BIOSCIENCES -0001 working capital to net assets ratio by year from 2021 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for KEYMED BIOSCIENCES -0001 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is KEYMED BIOSCIENCES -0001's balance sheet.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 57.2% | €1.59 Billion | €2.77 Billion | €2.42 Billion | €836.29 Million | ▼ -12.2 pp |
| 2024 | 69.4% | €1.72 Billion | €2.48 Billion | €2.47 Billion | €747.73 Million | ▼ -18.5 pp |
| 2023 | 87.9% | €2.63 Billion | €2.99 Billion | €2.94 Billion | €314.18 Million | ▲ +0.1 pp |
| 2022 | 87.8% | €2.93 Billion | €3.34 Billion | €3.31 Billion | €379.70 Million | ▼ -7.4 pp |
| 2021 | 95.2% | €3.47 Billion | €3.65 Billion | €3.58 Billion | €112.08 Million | — |